Pfiz­er set­tles EpiPen price hike law­suits for $345M

Pfiz­er has agreed to pay $345 mil­lion as part of a set­tle­ment re­lat­ed to a 5-year-old law­suit over the com­pa­ny’s price hikes on the life­sav­ing EpiPen.

Plain­tiffs across the coun­try raised con­cerns over the price of the au­toin­jec­tor 2-pack, which they said spiked from about $100 in 2007 to $608 in 2016 — an in­crease of over 600%.

“Were the price in­creas­es at­trib­ut­able to mar­ket con­di­tions, in­creas­es in man­u­fac­tur­ing costs, or short­ages in the sup­ply of ep­i­neph­rine? Ab­solute­ly not. They were dri­ven sole­ly by un­ac­count­able ex­ec­u­tives and com­pa­nies who sought to prof­it off of hu­man mis­ery and fear,” the con­sol­i­dat­ed class ac­tion com­plaint from 2017 al­leged.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER